(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VITALANT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VITALANT

ST13

US500000087743963

Class

35, 36, 39, 40, 41, 42, 44

Filing

87743963

Registration

5657555

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

09/03/2024

Trademark type

Word

Nice classes

35, 36, 39, 40, 41, 42, 44

Filing date

01/04/2018

Registration date

01/15/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/03/2024

Last transaction

09/03/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/24/2018

First use in commerce

09/24/2018

Drawing code

4

Owner type

03

Owner location

Scottsdale, AZ

Examiner

BRECKENFELD, WILLIAM

Current location

Historical data usage

Holders and representatives

Holders

VITALANT
Blood Systems, Inc.

Representatives

Emily A. Bayton FAEGRE DRINKER BIDDLE & REATH LLP

Technical classification

Nice Classes

Class 35Class 36Class 39Class 40Class 41Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Inventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitalsclinicshome care companieshemophilia and thrombosis centersphysician offices; promoting public awareness of the need for blood donorspublic awareness about blood products and community blood bank centers; arranging procurement of goods for others in the field of human bonetissueorgans for purposes of transplantation; and distributorship services in the field of human blood and blood productstherapeutic plasma-derivatives and recombinant coagulation products

Class 36

Charitable fundraising services in the field of human blood and blood products to support blood bank operations and research in the field of transfusion medicine

Class 39

Storage of human bonetissueorgans for purposes of transplantation

Class 40

Processing of human bonetissue and organs for purposes of transplantation

Class 41

Educational servicesproviding educational materials to the general public and health care professionals about blood donation and transfusion; providing training and continuing professional education courses in the field of healthsafetymedicineimmunologyblood bankingtransfusion and human resources and business management in the transfusion medicine and blood banking laboratory fields

Class 42

Laboratoryclinical and translational research in the field of transfusion medicineinfectious disease; blood analysis services; medical blood laboratory services; medical research in the field of blood; and providing quality assurance services in the field of blood and blood products

Class 44

Blood bank servicescollectionsupplypreservationdistributioncoordination of human blood and blood products; organ and tissue bank services; medical testing of blood; blood bank servicesprocessing of blood

Publications

History of USPTO decisions and trademark events.

40 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/03/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/03/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/03/2024

E815

TEAS SECTION 8 & 15 RECEIVED

02/13/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/15/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/26/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/26/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/26/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/26/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/26/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/13/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

01/15/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/11/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/10/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/19/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/19/2018

IUAF

USE AMENDMENT FILED

10/29/2018

EISU

TEAS STATEMENT OF USE RECEIVED

10/29/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/23/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/28/2018

PUBO

PUBLISHED FOR OPPOSITION

08/28/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/08/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/20/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/19/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/18/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/18/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/07/2018

GNRT

NON-FINAL ACTION E-MAILED

06/07/2018

CNRT

NON-FINAL ACTION WRITTEN

06/07/2018

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

05/31/2018

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

05/08/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/25/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/24/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

04/24/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/24/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

04/24/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/24/2018

DOCK

ASSIGNED TO EXAMINER

04/13/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/19/2018

NWAP

NEW APPLICATION ENTERED

01/08/2018

Continuous trademark protection

Get notified about every new filing that threatens VITALANT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.